Delivery Order SPE2DB20D1100-SPE2DB24FA0R8

Award Date 2/5/24
Potential Completion Date 2/6/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Fluticasone Prop HFA 110 mcg 12gm pharmaceutical products. The contract has a potential value of $2,124.52 and a period of performance through February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which does not...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, as a prime contractor. The contract is a firm fixed price delivery order for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a potential value of $1,850.73 and a completion date of February 21, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug...
This federal contract award, valued at $3,620.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4564222395 - Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with an ultimate completion date of April 10, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The $3,728.88 firm fixed price delivery order has a performance period through March 15, 2024. Amerisourcebergen Drug Corp previously received an indefinite delivery contract (IDC) from DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 110 MCG 12GM pharmaceuticals. The $6,296.40 award has a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of medications...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $8,762.72 firm fixed-price delivery order contract for the supply of Fluticasone Propionate HFA 220 MCG 12GM, a pharmaceutical product. This order was placed under an existing $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,084,872 units of Fluticasone Prop HFA 220 MCG 12GM. The contract, valued at $30,713.34, has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - Fluticasone Prop HFA 110 MCG 12GM. The contract has a potential value of $3,937.85 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceuticals and medical supplies to U.S. government agencies, notably the Department of...
This federal contract award is a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,238.15, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products. The contract has an ultimate completion date of April 3, 2024 and does not include a set-aside designation....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,923.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563652915 - FLUTICASONE PROP HFA 220 MCG 12GM. This contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not associated with any set-aside program. In addition, Amerisourcebergen Drug...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA0R8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $2,256.19 and a completion date of February 6, 2024. It is for the provision of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designation. In addition to this delivery order, Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 5/6/24, 9:30 AM